A phase I/II evaluation of sacituzumab tirumotecan plus pembrolizumab with chemotherapy in advanced esophageal squamous cell carcinoma (ESCC): Arm 5 of KEYMAKER-U06 substudy 06E

  • Yamamoto, S.; 
  • Shen, L.; 
  • Hsu, C-H.; 
  • Oliveira, S. C. S.; 
  • Doi, T.; 
  • ... Sun, J-M.; 
  • 외 7명
Citations

WEB OF SCIENCE

0
제목
A phase I/II evaluation of sacituzumab tirumotecan plus pembrolizumab with chemotherapy in advanced esophageal squamous cell carcinoma (ESCC): Arm 5 of KEYMAKER-U06 substudy 06E
저자
Yamamoto, S.; Shen, L.; Hsu, C-H.; Oliveira, S. C. S.; Doi, T.; Enzinger, P. c.; Kato, K.; Shah, M. A.; van Laarhoven, H. W. M.; Suttner, L.; Liu, Y.; Hatogai, K.; Sun, J-M.
DOI
10.1016/j.annonc.2026.05.690
발행일
2026-07
유형
Meeting Abstract
저널명
Annals of Oncology
권
37
페이지
S237 ~ S238